STARHEALTH
Star Health And Allied Insurance Company Limited
Each stock's 10,000-path forecast, rendered as light.
Star Health And Allied Insurance Company Limited (STARHEALTH) Stock Analysis & Case Study
Is STARHEALTH a good buy? The data-driven verdict.
Star Health And Allied Insurance Company Limited (STARHEALTH) trades at ₹570,on the numbers it tread carefully, a Downstox Snapshot Score of 39/100.
On the numbers, Star Health And Allied Insurance Company Limited (STARHEALTH) tread carefully, a Downstox Snapshot Score of 39/100, weighing premium at 39.7× earnings, ROE of 7.6%, a 58% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
STARHEALTH fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How STARHEALTH ranks against the 2,373 companies in our screener
- STARHEALTH's market cap of 33,540 Cr ranks in the 89th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- STARHEALTH's book value of ₹129 ranks in the 60th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- STARHEALTH's promoter holding of 58.0% ranks in the 47th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- STARHEALTH's 3-year profit (PAT) growth of -3.0% ranks in the 26th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- STARHEALTH's 3-year revenue growth of 14.0% ranks in the 60th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- STARHEALTH's debt-to-equity ratio of 0.06x is lower than 84% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is STARHEALTH overvalued? STARHEALTH P/E vs peers
STARHEALTH trades at 39.7× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
STARHEALTH share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 4.6y of STARHEALTH history (-10%/yr drift, 26%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| STARHEALTH 2027 | ₹435 | ₹601 | ₹830 | +5% |
| STARHEALTH 2028 | ₹399 | ₹634 | ₹1,006 | +11% |
| STARHEALTH 2029 | ₹379 | ₹668 | ₹1,177 | +17% |
| STARHEALTH 2030 | ₹360 | ₹705 | ₹1,378 | +24% |
| STARHEALTH 2031 | ₹359 | ₹743 | ₹1,538 | +30% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability STARHEALTH goes up, or doubles?
The bull case for STARHEALTH
- Star Health And Allied Insurance Company Limited is part of the nifty100 universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹1,177.
The bear case & risks
- STARHEALTH's P/E of 39.7x is lower than 34% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- STARHEALTH's return on equity of 7.6% ranks in the 38th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹379.
STARHEALTH volatility & expected range, how bumpy is the ride?
Over the last 4.6 years STARHEALTH compounded at -10%/year with annualized volatility of 26%. That volatility implies a 1-year 80% range of ₹435-₹830, the honest backbone behind any single price target.
STARHEALTH price forecast, the full 60-month probability fan
STARHEALTH price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds STARHEALTH hits common targets within the simulated horizon?
Full multi-horizon detail on the STARHEALTH price target & forecast page.
STARHEALTH Piotroski F-Score: 4/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. STARHEALTH scores 4/8, mixed financial health.
STARHEALTH MTF margin & leverage across 11 brokers
Margin Trading Facility lets you buy STARHEALTH with part of the capital. Lower margin % = higher leverage. Rates compared across 11 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 27.37% | 3.7× |
| Zerodha | 27.35% | 3.7× |
| Groww | 27.38% | 3.7× |
| Dhan | 27.35% | 3.7× |
| Kotak Neo | 30.03% | 3.3× |
| Paytm Money | 28.07% | 3.6× |
| PocketfulCHEAPEST | 27.32% | 3.7× |
| Fyers | 27.78% | 3.6× |
| Anand Rathi | 27.35% | 3.7× |
| Bajaj Broking | 29.00% | 3.4× |
| Share India | 27.38% | 3.7× |
Compare every broker on the STARHEALTH MTF page.
Which ace investors hold STARHEALTH?
Held by 1 tracked superstar investor (from public NSE/BSE disclosures):
About Star Health And Allied Insurance Company Limited: sector, index & market-cap context
Star Health And Allied Insurance Company Limited (STARHEALTH) is a mid-cap NSE-listed company, and a constituent of the Nifty 500 index, with a market capitalisation of ₹33,540 Cr. See more stocks on our screener.
How the STARHEALTH Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Star Health And Allied Insurance Company Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
STARHEALTH analysis, FAQs
Is Star Health And Allied Insurance Company Limited (STARHEALTH) a good buy?
On the numbers, Star Health And Allied Insurance Company Limited (STARHEALTH) tread carefully, a Downstox Snapshot Score of 39/100, weighing premium at 39.7× earnings, ROE of 7.6%, a 58% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is STARHEALTH overvalued or undervalued?
STARHEALTH trades at 39.7× earnings, premium versus the ~22× long-run Nifty average.
What is the STARHEALTH share price target for 2031?
STARHEALTH's probability-weighted 2031 median target is ₹743, with an 80% range of ₹359-₹1,538 (10,000-path Monte-Carlo).
What is the probability STARHEALTH doubles in 5 years?
The modelled probability of STARHEALTH reaching ₹1,140 (2×) within 5 years is 22%.
What is the bull case for STARHEALTH?
Star Health And Allied Insurance Company Limited is part of the nifty100 universe with live, tracked fundamentals on Downstox.
What are the risks in STARHEALTH?
STARHEALTH's P/E of 39.7x is lower than 34% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. STARHEALTH's return on equity of 7.6% ranks in the 38th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.